Coagulopathy and COVID?19

dc.authorid
dc.contributor.authorYazıcı, Onur
dc.contributor.authorBozkus, Fulsen
dc.contributor.authorDemirci, Nilgun Yilmaz
dc.contributor.authorGülhan, Pınar Yıldız
dc.contributor.authorCoskun, Funda
dc.date.accessioned2021-12-01T18:23:26Z
dc.date.available2021-12-01T18:23:26Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractCaused by severe acute respiratory syndrome?coronavirus?2 (SARS?CoV?2), coronavirus disease2019 (COVID?19) is a potentially fatal disease as a global public health issue. Several mechanismsmay be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulationcaused by SARS?CoV?2. When patients have coagulation disorders, treatment becomes morechallenging and mortality rate increases accordingly. The aim of this article is to review the potentialmechanisms of coagulopathy in COVID?19 in light of literature data.en_US
dc.identifier.doi10.4103/ejop.ejop_49_20
dc.identifier.endpage69en_US
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue1en_US
dc.identifier.startpage67en_US
dc.identifier.urihttps://doi.org/10.4103/ejop.ejop_49_20
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpnNE9EazVPUT09
dc.identifier.urihttps://hdl.handle.net/20.500.12684/9707
dc.identifier.volume22en_US
dc.identifier.wosWOS:000578603800014en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.relation.ispartofEurasian Journal of Pulmonologyen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleCoagulopathy and COVID?19en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9707.pdf
Boyut:
731.45 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text